FFN
IBB icon

Focus Financial Network’s iShares Biotechnology ETF IBB Stock Holding History

Focus Financial Network’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
5,697
-523
-8% -$89.9K 0.03% 327
2026
Q1 		$1.05M Sell
6,220
-851
-12% -$146K 0.04% 306
2025
Q4 		$1.19M Sell
7,071
-102
-1% -$16.6K 0.04% 276
2025
Q3 		$1.04M Sell
7,173
-145
-2% -$19.8K 0.04% 294
2025
Q2 		$926K Buy
7,318
+158
+2% +$19.4K 0.04% 308
2025
Q1 		$916K Sell
7,160
-741
-9% -$100K 0.04% 294
2024
Q4 		$1.04M Sell
7,901
-87
-1% -$12.2K 0.04% 273
2024
Q3 		$1.16M Sell
7,988
-159
-2% -$23K 0.05% 258
2024
Q2 		$1.19M Buy
8,147
+15
+0.2% +$2K 0.05% 245
2024
Q1 		$1.01M Sell
8,132
-3,393
-29% -$463K 0.05% 252
2023
Q4 		$1.57M Sell
11,525
-21,526
-65% -$2.63M 0.06% 241
2023
Q3 		$4.04M Sell
33,051
-2,607
-7% -$332K 0.23% 87
2023
Q2 		$4.53M Buy
35,658
+252
+0.7% +$32.7K 0.25% 84
2023
Q1 		$4.57M Sell
35,406
-131
-0.4% -$17.1K 0.28% 79
2022
Q4 		$4.67M Sell
35,537
-7,303
-17% -$944K 0.38% 54
2022
Q3 		$5.01M Sell
42,840
-2,891
-6% -$359K 0.43% 45
2022
Q2 		$5.38M Buy
45,731
+893
+2% +$106K 0.44% 42
2022
Q1 		$5.84M Buy
44,838
+40,740
+994% +$5.31M 0.41% 44
2021
Q4 		$625K Buy
4,098
+162
+4% +$25.1K 0.09% 192
2021
Q3 		$636K Sell
3,936
-23
-0.6% -$3.87K 0.08% 211
2021
Q2 		$648K Hold
3,959
– – 0.09% 218
2021
Q1 		$596K Sell
3,959
-7,461
-65% -$1.19M 0.07% 225
2020
Q4 		$1.73M Buy
11,420
+2,665
+30% +$381K 0.15% 125
2020
Q3 		$1.19M Buy
8,755
+1,594
+22% +$216K 0.11% 164
2020
Q2 		$979K Buy
7,161
+4,675
+188% +$596K 0.11% 164
2020
Q1 		$268K Sell
2,486
-360
-13% -$41.4K 0.04% 294
2019
Q4 		$343K Buy
2,846
+1
+0% +$112 0.04% 288
2019
Q3 		$283K Sell
2,845
-60
-2% -$6.28K 0.04% 304
2019
Q2 		$317K Sell
2,905
-32
-1% -$3.4K 0.05% 274
2019
Q1 		$328K Buy
+2,937
New +$322K 0.05% 256

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Focus Financial Network's IBB Position: Q2 2026 in Review

Focus Financial Network reduced its iShares Biotechnology ETF (IBB) stake by 8.4% in Q2 2026, selling an estimated $89.9K and leaving 5,697 shares worth $1.08M. The position accounts for 0.03% of the portfolio, ranked #327.

Focus Financial Network first reported a position in IBB in Q1 2019 and has held it in 30 quarters since. The position peaked at $5.84M in Q1 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Focus Financial Network held 5,697 shares of iShares Biotechnology ETF worth $1.08M as of Q2 2026.
  • Focus Financial Network sold 523 iShares Biotechnology ETF shares in Q2 2026, an estimated $89.9K.
  • iShares Biotechnology ETF made up 0.03% of Focus Financial Network's portfolio in Q2 2026, its #327 holding.
  • Focus Financial Network first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 30 quarters since.
  • Focus Financial Network's iShares Biotechnology ETF position peaked at $5.84M in Q1 2022.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.